» Articles » PMID: 39493189

Proton Radiation Therapy for Head and Neck Cancers

Overview
Journal Cureus
Date 2024 Nov 4
PMID 39493189
Authors
Affiliations
Soon will be listed here.
Abstract

Head and neck (HnN) cancers are among the most common cancers in the world. Proton therapy (PT) is one of the latest advancements in the treatment modalities of cancers. Proton therapy is specifically used to treat HnN cancer patients due to its less toxic effects on the surrounding critical structures. Keeping in view the opportunities for further advancements, there is a lot of literature covering PT in HnN cancer patients. However, few compiled studies are not enough to compare the toxicities, overall survival (OS), local control (LC), and quality of life (QoL) of PT with that of intensity-modulated radiation therapy (IMRT). The objective of this review is to compile and summarize the literature available on the toxicities, OS, LC, and QoL in HnN cancer patients post PT. We have gathered and summarized the literature found under the keyword "proton therapy for head and neck cancers". Proton therapy is a preferable option over IMRT because it isolates tumors of the HnN, reduces exposure of healthy cells to radiation, and allows accurate tumor scanning using the pencil beam technique. In view of this article, we can say that PT is a preferable mode of radiotherapy for HnN cancer patients in view of its accuracy and lower incidents of acute and late toxicities.

References
1.
Mendenhall W, Morris C, Amdur R, Werning J, Hinerman R, Villaret D . Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004; 26(2):154-62. DOI: 10.1002/hed.10380. View

2.
Brennan B . Nasopharyngeal carcinoma. Orphanet J Rare Dis. 2006; 1:23. PMC: 1559589. DOI: 10.1186/1750-1172-1-23. View

3.
Kandula S, Zhu X, Garden A, Gillin M, Rosenthal D, Ang K . Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim. 2013; 38(4):390-4. DOI: 10.1016/j.meddos.2013.05.001. View

4.
Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P . Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95(23):1772-83. DOI: 10.1093/jnci/djg107. View

5.
Johnson D, Burtness B, Leemans C, Lui V, Bauman J, Grandis J . Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1):92. PMC: 7944998. DOI: 10.1038/s41572-020-00224-3. View